发明名称 Agent for Eliminating Multidrug Resistance
摘要 The invention belongs to medicine, namely to pharmacology, and may be used to overcome multiple drug resistance in oncological and infectious patients undergoing long-term chemotherapy. Essence of the invention: proposed herein as a therapeutic agent intended to overcome multiple drug resistance is a hexapeptide with the following structural formula: lysyl-histidyl-glycyl-lysyl-histidyl-glycine.
申请公布号 US2016022762(A1) 申请公布日期 2016.01.28
申请号 US201514853529 申请日期 2015.09.14
申请人 LEBEDEV Vasiliy V. 发明人 LEBEDEV Vasiliy V.
分类号 A61K38/08;A61K45/06;A61K9/02;A61K9/00;A61K9/08 主分类号 A61K38/08
代理机构 代理人
主权项 1. A method for preventing or treating multiple drug resistance in a patient comprising administering an effective amount of a therapeutic agent comprising a hexapeptide with the following structural formula: lysyl-histidyl-glycyl-lysyl-histidyl-glycine (SEQ ID NO: 1) and a target additive prior to and during chemoradiotherapy.
地址 Moscow RU